Literature DB >> 9076510

Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.

J Müthing1, M Cacić.   

Abstract

In this study the comparative TLC immunostaining investigation of neutral GSLs and gangliosides from human skeletal and heart muscle is described. A panel of specific polyclonal and monoclonal antibodies as well as the GM1-specific choleragenoid were used for the overlay assays, combined with preceding neuraminidase treatment of gangliosides on TLC plates. This approach proved homologies but also quantitative and qualitative differences in the expression of ganglio-, globo- and neolacto-series neutral GSLs and gangliosides in these two types of striated muscle tissue within the same species. The main neutral GSL in skeletal muscle was LacCer, followed by GbOse3Cer, GbOse4Cer, nLcOse4Cer and monohexosylceramide, whereas in heart muscle GbOse3Cer and GbOse4Cer were the predominant neutral GSLs beside small quantities of LacCer, nLcOse4Cer and monohexosylceramide. No ganglio-series neutral GSLs and no Forssman GSL were found in either muscle tissue. GM3(Neu5Ac) was the major ganglioside, comprising almost 70% in skeletal and about 50% in cardiac muscle total gangliosides. GM2 was found in skeletal muscle only, while GD3 and GM1b-type gangliosides (GM1b and GD1 alpha) were undetectable in both tissues. GM1a-core gangliosides (GM1, GD1a, GD1b and GT1b) showed somewhat quantitative differences in each muscle; lactosamine-containing IV3Neu5Ac-nLcOse4Cer was detected in both specimens. Neutral GSLs were identified in TLC runs corresponding to e.g. 0.1 g muscle wet weight (GbOse3Cer, GbOse4Cer), and gangliosides GM3 and GM2 were elucidated in runs which corresponded to 0.2 g muscle tissue. Only 0.02 g and 0.004 g wet weight aliquots were necessary for unequivocal identification of neolacto-type and GM1-core gangliosides, respectively. Muscle is known for the lowest GSL concentration from all vertebrate tissues studied so far. Using the overlay technique, reliable GSL composition could be revealed, even from small muscle probes on a sub-orcinol and sub-resorcinol detection level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076510     DOI: 10.1023/a:1018552729572

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  75 in total

Review 1.  Invited review: myoblast transfer: a possible therapy for inherited myopathies?

Authors:  T A Partridge
Journal:  Muscle Nerve       Date:  1991-03       Impact factor: 3.217

2.  Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

Authors:  J Dhawan; L C Pan; G K Pavlath; M A Travis; A M Lanctot; H M Blau
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

3.  Gangliosides that modulate membrane protein function.

Authors:  Y Igarashi; H Nojiri; N Hanai; S Hakomori
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

Review 4.  Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells.

Authors:  M Fukuda
Journal:  Biochim Biophys Acta       Date:  1985

5.  Characterization of two gangliosides of the paragloboside series from chicken skeletal muscle.

Authors:  J L Chien; E L Hogan
Journal:  Biochim Biophys Acta       Date:  1980-12-05

6.  Regulation of glycolipid synthesis during differentiation of clonal murine muscle cells.

Authors:  K C Leskawa; E L Hogan
Journal:  Mol Cell Biochem       Date:  1990-08-10       Impact factor: 3.396

7.  Selective detection of terminally alpha 2-3 and alpha 2-6 sialylated neolacto-series gangliosides by immunostaining on thin layer chromatograms.

Authors:  J Müthing; U Neumann
Journal:  Biomed Chromatogr       Date:  1993 May-Jun       Impact factor: 1.902

8.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.

Authors:  K R McCurry; D L Kooyman; C G Alvarado; A H Cotterell; M J Martin; J S Logan; J L Platt
Journal:  Nat Med       Date:  1995-05       Impact factor: 53.440

9.  Forssman glycolipid, an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes.

Authors:  U Bethke; B Kniep; P F Mühlradt
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

10.  Systemic delivery of recombinant proteins by genetically modified myoblasts.

Authors:  E Barr; J M Leiden
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  8 in total

1.  Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.

Authors:  George Dalton; Sung-Wan An; Saif I Al-Juboori; Nicole Nischan; Joonho Yoon; Evgenia Dobrinskikh; Donald W Hilgemann; Jian Xie; Kate Luby-Phelps; Jennifer J Kohler; Lutz Birnbaumer; Chou-Long Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

2.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

3.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

4.  Newcastle Disease Virus Entry into Chicken Macrophages via a pH-Dependent, Dynamin and Caveola-Mediated Endocytic Pathway That Requires Rab5.

Authors:  Ran Zhao; Qiankai Shi; Zongxi Han; Zhen Fan; Hui Ai; Linna Chen; Le Li; Tianyi Liu; Junfeng Sun; Shengwang Liu
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Adult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy.

Authors:  Osamu Suzuki; Takao Kanai; Toshio Nishikawa; Yoshie Yamamoto; Akira Noguchi; Kazuhiro Takimoto; Minako Koura; Yoko Noguchi; Kozue Uchio-Yamada; Shuichi Tsuji; Junichiro Matsuda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 6.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

Review 7.  Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase.

Authors:  Laura Monturiol-Gross; Fabian Villalta-Romero; Marietta Flores-Díaz; Alberto Alape-Girón
Journal:  FEBS Open Bio       Date:  2021-11-08       Impact factor: 2.693

8.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.